Valentina Hoyos, MD
Disclosures: Royalties or Patent Beneficiary-Takeda Pharmaceutical (Relationship has ended)|Stocks or stock options, excluding diversified mutual funds-Allovir|Stocks or stock options, excluding diversified mutual funds-Marker Therapeutics - 04/14/2022
To display the PDF download directly in your browser, please install the Adobe Acrobat Reader plugin. If you do not want to install the plugin, you can download your file here: Faculty Bio